1-4 of 4
Hui Cheng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV− and HPV+ Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy

Roy Xiao, Yi An, Wenda Ye, Adeeb Derakhshan, Hui Cheng, Xinping Yang, Clint Allen, Zhong Chen, Nicole C. Schmitt, Carter Van Waes
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (21): 6463–6474.
https://doi.org/10.1158/1078-0432.CCR-18-3802
Published: 01 November 2019
View article titled, Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV<sup>−</sup> and HPV<sup>+</sup> Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy
Open the PDF for Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV<sup>−</sup> and HPV<sup>+</sup> Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy in another window
Includes: Supplementary data
Journal Articles

Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer

Anthony D. Saleh, Hui Cheng, Scott E. Martin, Han Si, Pinar Ormanoglu, Sophie Carlson, Paul E. Clavijo, Xinping Yang, Rita Das, Shaleeka Cornelius, Jamie Couper, Douglas Chepeha, Ludmila Danilova, Thomas M. Harris, Michael B. Prystowsky, Geoffrey J. Childs, Richard V. Smith, A. Gordon Robertson, Steven J. M. Jones, Andrew D. Cherniack, Sang S. Kim, Antonina Rait, Kathleen F. Pirollo, Esther H. Chang, Zhong Chen, Carter Van Waes
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (9): 2860–2873.
https://doi.org/10.1158/1078-0432.CCR-18-0716
Published: 01 May 2019
View article titled, Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer
Open the PDF for Integrated Genomic and Functional microRNA Analysis Identifies miR-30-5p as a Tumor Suppressor and Potential Therapeutic Nanomedicine in Head and Neck Cancer in another window
Includes: Supplementary data
Journal Articles

MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma

Suresh Mohan, Robert Vander Broek, Sujay Shah, Danielle F. Eytan, Matthew L. Pierce, Sophie G. Carlson, Jamie F. Coupar, Jialing Zhang, Hui Cheng, Zhong Chen, Carter Van Waes
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (17): 3946–3956.
https://doi.org/10.1158/1078-0432.CCR-14-3377
Published: 31 August 2015
View article titled, MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma
Open the PDF for MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer

Amanda Herzog, Yansong Bian, Robert Vander Broek, Bradford Hall, Jamie Coupar, Hui Cheng, Anastasia L. Sowers, John D. Cook, James B. Mitchell, Zhong Chen, Ashok B. Kulkarni, Carter Van Waes
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (14): 3808–3819.
https://doi.org/10.1158/1078-0432.CCR-12-2716
Published: 15 July 2013
View article titled, PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer
Open the PDF for PI3K/mTOR Inhibitor PF-04691502 Antitumor Activity Is Enhanced with Induction of Wild-Type TP53 in Human Xenograft and Murine Knockout Models of Head and Neck Cancer in another window
Includes: Supplementary data